Page-2 of Pfizer
Pfizer-BioNTech to provide 2 billion Covid-19 vaccine to Poor Nations
In a bid to fulfil the international calls for vaccine solidarity, American pharmaceutical company, Pfizer and German company, BioNTech have pledged to provide 2 billion doses of Covid-19 vaccine to poor countries in middle-income and low-income countries in next 18 ..
Month: Current Affairs - May, 2021
Mixing Covid-19 vaccines increase Vaccine Reactogenicity
The researchers in the University of Oxford recently launched “Com-COV Study “. The study was launched to investigate alternate doses of Pfizer-BioNTech vaccine and Oxford-Astra Zeneca vaccine. The researchers have concluded that mixing the administration of these doses in a ..
Month: Current Affairs - May, 2021
Sinopharm Vaccine approved by WHO
The World Health Organisation recently approved the Emergency Use of Sinpharm vaccine. Recently, the WHO approved COVID-19 vaccines developed by AstraZeneca, Pfizer, BioNTech, Johnson and Johnson as well. The other popular Chinese Vaccine is sinovac. Sinopharm Vaccine Sinopharm vaccine was ..
Month: Current Affairs - May, 2021
Intellectual Property Waiver for COVID Vaccines
India and South Africa proposed for IP waiver at the World Trade Organisation in 2020. This has now been backed by the United States. The US will further negotiate at the World Trade Organisation to waive Intellectual property for COVID-19 ..
Month: Current Affairs - May, 2021
What is Stop Tokyo Olympics?
The Stop Tokyo Olympics is an online campaign that is wanting to stop the Tokyo Olympics Games. It has gathered more than 200,000 signatures within two days of its launch. However, the organisers of the Olympic Games are to go ..
Month: Current Affairs - May, 2021
COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the ..